Black patients fare well on new hepatitis C drug

NEW YORK (Reuters) - A closer look at data from a late stage trial of Vertex Pharmaceuticals Inc's eagerly anticipated hepatitis C drug called telaprevir showed impressive cure rates for black patients and for patients with advanced liver disease.

Continue to Black patients fare well on new hepatitis C drug on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz